Long-term sleep laboratory evaluation of flunitrazepam

M. B. Scharf, E. O. Bixler, A. Kales, C. R. Soldatos

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


A sleep laboratory hypnotic drug evaluation study was conducted in which 2 mg flunitrazepam, a benzodiazepine with a half life of intermediate duration, was administered nightly to 6 insomniac subjects for 4 consecutive weeks. The drug was effective with short-term use. However, tolerance developed for sleep maintenance during the intermediate- and long-term drug administration periods. Following drug withdrawal, a significant worsening of sleep above baseline levels occurred. These data are consistent with our previous findings of rebound insomnia following withdrawal of short- and intermediate-acting benzodiazepines.

Original languageEnglish (US)
Pages (from-to)173-181
Number of pages9
Issue number4
StatePublished - 1979

All Science Journal Classification (ASJC) codes

  • Pharmacology


Dive into the research topics of 'Long-term sleep laboratory evaluation of flunitrazepam'. Together they form a unique fingerprint.

Cite this